Current state of the art and future of myectomy

Magdi H Yacoub1,2, Ahmed Afifi2, Hesham Saad2

  • 1National Heart and Lung Institute, Imperial College London, London, UK.

Insights

Surgical relief of left ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy (HCM) is effective but requires a personalized approach. This gold standard treatment, though underused, offers predictable long-term outcomes with low risks.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) often causes symptomatic left ventricular outflow tract obstruction (LVOTO).
  • Septal myectomy is the gold standard surgical treatment for symptomatic HCM patients without comorbidities.
  • Effective LVOTO relief necessitates an individualized surgical strategy.

Purpose of the Study:

  • To emphasize the comprehensive nature of surgical LVOTO relief in HCM.
  • To highlight the importance of advanced imaging and tailored surgical techniques.
  • To advocate for increased utilization of this effective treatment.

Main Methods:

  • Preoperative multimodality imaging and numerical modeling to identify obstructive components.
  • Intraoperative transesophageal echocardiography (TEE) to guide the procedure and assess repair adequacy.
  • Individualized septal myectomy addressing fibrous trigones, accessory tissues, and papillary muscle anomalies.

Main Results:

  • The mitral valve can be preserved in nearly all patients.
  • The procedure demonstrates very low mortality and morbidity rates.
  • Predictable good short-term and long-term outcomes are achievable.

Conclusions:

  • Surgical LVOTO relief in HCM is a safe and effective procedure with excellent outcomes.
  • A multidisciplinary approach utilizing advanced imaging is crucial for successful repair.
  • Despite its benefits, surgical intervention for LVOTO in HCM remains significantly underutilized.

Related Concept Videos